AVENUE THERAPEUTICS, INC. (ATXI) AI Dilution Summary
Updated Nov 9, 2026
Cash was $1,520,000 at the 2026-09-30 balance-sheet date, against estimated monthly burn of $140,667. Dilution here is driven primarily by the Series C Warrants from the May 2024 warrant inducement. They cover 689,680 underlying shares at a fixed $6.20 exercise price and expire 2029-05-01.